Clincosm LogoSign in Get a demo

primary peritoneal cancer

Showing 26 - 50 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Serous Ovarian, Fallopian Tube, Primary Peritoneal Cancer Trial in New York (Carboplatin and Paclitaxel, Nivolumab,

Active, not recruiting
  • High Grade Serous Ovarian
  • +2 more
  • Carboplatin and Paclitaxel
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 13, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Springfield (Omega Nutrition cold-milled

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Omega Nutrition cold-milled flaxseeds
  • Springfield, Illinois
    Southern Illinois University School of Medicine
Mar 30, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (GEN-1)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • GEN-1
  • Birmingham, Alabama
  • +3 more
Mar 29, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (GEN-1, Carboplatin,

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • GEN-1
  • +2 more
  • Birmingham, Alabama
  • +23 more
Mar 7, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Japan (Niraparib)

Active, not recruiting
Has Results
  • Ovarian Cancer
  • +2 more
  • Nagoya, Aichi, Japan
  • +26 more
Feb 7, 2022

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jan 25, 2022

Malignant Tumors of Female Genital Organs, Ovarian Cancer, Fallopian Tube Cancer Trial in Houston (Bevacizumab)

Recruiting
  • Malignant Neoplasms of Female Genital Organs
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 3, 2022

Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • +4 more
  • Birmingham, Alabama
  • +15 more
Dec 13, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • OC-L/Montanide ISA 51 VG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 18, 2021

Ovarian Endometrioid Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Ovarian Endometrioid Tumor
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 21, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Germany (Rucaparib, Placebos)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Berlin, Germany
  • +22 more
Aug 30, 2021

Patients With Platinum Sensitive Recurrent Ovarian Cancer

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Santiago De Compostela, A Coruña, Spain
  • +56 more
Aug 4, 2021

Advanced Solid Tumours, Breast Cancer, Ovarian Cancer Trial in Blacktown, Kogarah, Melbourne (IMP4297)

Completed
  • Advanced Solid Tumours
  • +4 more
  • Blacktown, New South Wales, Australia
  • +2 more
Mar 27, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Minneapolis (FATE-NK100, Interleukin-2)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Mar 10, 2021

Advanced Ovarian Cancer, Primary Peritoneal Cancer, Advanced Breast Cancer Trial run by the NCI (BMN 673)

Completed
Has Results
  • Advanced Ovarian Cancer
  • +3 more
  • BMN 673
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 2, 2021

Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in New York, Philadelphia, Charlottesville

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • New York, New York
  • +2 more
Jan 20, 2021

Ovarian Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial run by the NCI (Bevacizumab, BAY 43-9006)

Completed
Has Results
  • Ovarian Neoplasm
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020

Ovarian Epithelial Cancer Recurrent, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Worldwide (PankoMab-GEX, Placebo)

Completed
  • Ovarian Epithelial Cancer Recurrent
  • +2 more
  • Berlin, Germany
  • +49 more
Oct 20, 2020

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in United States (Paclitaxel,, Bevacizumab, Cisplatin)

Completed
  • Ovarian Cancer
  • +2 more
  • Basking Ridge, New Jersey
  • +4 more
Aug 20, 2020

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Japan (Niraparib)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Nagoya, Aichi, Japan
  • +32 more
Jul 28, 2020

Ovarian Carcinoma, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-DC vaccine, Bevacizumab,

Terminated
  • Ovarian Carcinoma
  • +2 more
  • OC-DC vaccine
  • +4 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 22, 2020

Primary Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L, Montanide, poly-ICLC

Terminated
  • Primary Ovarian Cancer
  • +2 more
  • OC-L
  • +2 more
  • Philadelphia, Pennsylvania
    Ovarian Cancer Research Center
Apr 23, 2020

Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Chuo-ku (Paclitaxel+Carboplatin)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital
Feb 12, 2020

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (AMG 386, Paclitaxel, AMG 386 Placebo)

Completed
  • Ovarian Cancer
  • +2 more
  • AMG 386
  • +2 more
  • (no location specified)
Dec 16, 2019

Ovarian Cancer, Breast Cancer, Primary Peritoneal Cancer Trial run by the NCI (Carboplatin, Olaparib)

Completed
  • Ovarian Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019